About Us

Precision Biotechnology for the Human Heart.

From experimental models to electrophysiology research, Virelion studies human cardiac function using iPSC-based systems and translational cardiac biology approaches.

Who We Are

Who We Are

Virelion is a team of innovators dedicated to transforming cardiac care through minimally invasive technologies. We help clinicians restore heart function, optimize interventions, and push the boundaries of cardiovascular medicine.

0 Hospitals

Healthcare institutions have improved patient outcomes using Virelion’s cardiac technologies.

0 Procedures

Delivering advanced interventions and circulatory support with precision and safety.

-% Success Rate

Clinicians see improved patient outcomes within the first months of implementing our research.

-% Success Rate

Clinicians see improved patient outcomes within the first months of implementing our research.

Our Values

The Values Behind Virelion

Our values guide every innovation. From precision to patient safety, we’re committed to developing cardiac solutions that save lives and advance interventional cardiology.

Driving Innovation Forward

Our values drive innovations that save lives and advance regenrative cardiology.

Committed to Integrity & Trust

Patient safety, compliance, and transparency are at the core of everything we do.

Empowering Cardiac Health

We enable hospitals and clinics to improve patient outcomes and streamline complex interventions.

Putting Patients First

Patient well-being is our top priority — we design solutions that truly make an impact on cardiac care.

Putting Patients First

Patient well-being is our top priority — we design solutions that truly make an impact on cardiac care.

Out Team

Meet the Minds Behind Virelion

We bring together cardiology, biomedical engineering, and AI expertise to create next-generation heart technologies that save lives and advance the field of interventional cardiology.

Create a free website with Framer, the website builder loved by startups, designers and agencies.